<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35109781</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines.</ArticleTitle>
        <Pagination>
          <StartPage>616</StartPage>
          <EndPage>628</EndPage>
          <MedlinePgn>616-628</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2037393</ELocationID>
        <Abstract>
          <AbstractText>Previous studies have revealed multiple tissue- or cell-specific or enriched miRNA profiles. However, miRNA profiles enriched in hepatic cell types and their effect on HBV replication have not been well elucidated. In this study, primary human hepatocytes (PHHs), Kupffer cells (KCs), liver sinusoidal endothelial cells (LSECs), and hepatic stellate cells (HSCs) were prepared from liver specimens of non-HBV-infected patients. Four hepatic cell type-enriched miRNA profiles were identified from purified liver cells miRNA microarray assay. The results revealed that 12 miRNAs, including miR-122-5p and miR-192-3p were PHH-enriched; 9 miRNAs, including miR-142-5p and miR-155-5p were KC-enriched; 6 miRNAs, including miR-126-3p and miR-222-3p were LSEC-enriched; and 14 miRNAs, including miR-214-3p and miR-199a-3p were HSC-enriched. By testing the effect of 11 PHH-enriched miRNAs on HBV production, we observed that miR-192-3p had the greatest pro-virus effect in hepatic cell lines. Moreover, we further found that miR-192-3p promoted HBV replication and gene expression through inhibiting Akt/mTOR signalling by direct targeting of ZNF143 in HepG2.2.15 cells. Additionally, the serum and hepatic miR-192-3p expression levels were significantly higher in chronic hepatitis B patients than in healthy controls and serum miR-192-3p positively correlated with the serum levels of HBV DNA and HBsAg. Collectively, we identified miRNA profiles enriched in four hepatic cell types and revealed that PHH-enriched miR-192-3p promoted HBV replication through inhibiting Akt/mTOR signalling by direct targeting of ZNF143 in hepatic cell lines. Our study provides a specific perspective for the role of hepatic cell type-enriched miRNA in interaction with viral replication and various liver pathogenesis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Fahong</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0002-7130-6707</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Yingying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Molecular Biology of Infectious Diseases (Chinese Ministry of Education), Chongqing Medical University, Chongqing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shenyan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Beidi</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Jinyu</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xueyu</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Zhenyu</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Molecular Biology of Infectious Diseases (Chinese Ministry of Education), Chongqing Medical University, Chongqing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Deng</LastName>
            <ForeName>Wanyu</ForeName>
            <Initials>W</Initials>
            <Identifier Source="ORCID">0000-0001-7789-3861</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biliary Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Richeng</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Zhongliang</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Jieliang</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Broering</LastName>
            <ForeName>Ruth</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Yong</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0001-9171-0195</Identifier>
            <AffiliationInfo>
              <Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Molecular Biology of Infectious Diseases (Chinese Ministry of Education), Chongqing Medical University, Chongqing, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lu</LastName>
            <ForeName>Mengji</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Jiming</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0001-5820-950X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Jing'An Branch of Huashan Hospital, Fudan University, Shanghai, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C546783">MIRN192 microRNA, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C547397">MIRN214 microRNA, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C114253">ZNF143 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.1.1</RegistryNumber>
          <NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006515" MajorTopicYN="Y">Hepatitis B virus</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Abbreviations: CMIA: chemiluminescent microparticle immunoassay</Keyword>
        <Keyword MajorTopicYN="N">Akt/mTOR signalling</Keyword>
        <Keyword MajorTopicYN="N">HBV: hepatitis B virus</Keyword>
        <Keyword MajorTopicYN="N">HSC: hepatic stellate cell</Keyword>
        <Keyword MajorTopicYN="N">KC: Kupffer cell</Keyword>
        <Keyword MajorTopicYN="N">LSEC: liver sinusoidal endothelial cell</Keyword>
        <Keyword MajorTopicYN="N">MiRNA profile</Keyword>
        <Keyword MajorTopicYN="N">PHH: primary human hepatocyte</Keyword>
        <Keyword MajorTopicYN="N">RI: replicative intermediate</Keyword>
        <Keyword MajorTopicYN="N">ZNF143</Keyword>
        <Keyword MajorTopicYN="N">hepatitis B virus</Keyword>
        <Keyword MajorTopicYN="N">miR-192-3p</Keyword>
        <Keyword MajorTopicYN="N">pgRNA: pregenomic RNA</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>3</Day>
          <Hour>5</Hour>
          <Minute>27</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35109781</ArticleId>
        <ArticleId IdType="pmc">PMC8865105</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2022.2037393</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Schweitzer A, Horn J, Mikolajczyk RT, et al. . 
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26231459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang TJ.
Hepatitis B: the virus and disease. Hepatology. 2009;49:S13–S21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2809016</ArticleId>
            <ArticleId IdType="pubmed">19399811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebosse F, Testoni B, Fresquet J, et al. . 
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. J Hepatol. 2017;66:897–909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28043874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Li F, Zhang X, et al. . 
Differentially expressed intrahepatic genes contribute to control of hepatitis B virus replication in the inactive carrier phase. J Infect Dis. 2018;217:1044–1054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29300924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alpini G, Phillips JO, Vroman B, et al. . 
Recent advances in the isolation of liver cells. Hepatology. 1994;20:494–514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8045510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levrero M, Zucman-Rossi J.. 
Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84–S101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27084040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ambros V.
The functions of animal microRNAs. Nature. 2004;431:350–355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15372042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landgraf P, Rusu M, Sheridan R, et al. . 
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401–1414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2681231</ArticleId>
            <ArticleId IdType="pubmed">17604727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ludwig N, Leidinger P, Becker K, et al. . 
Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865–3877.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4856985</ArticleId>
            <ArticleId IdType="pubmed">26921406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oda S, Takeuchi M, Akai S, et al. . 
miRNA in rat liver sinusoidal endothelial cells and hepatocytes and application to circulating biomarkers that discern pathogenesis of liver injuries. Am J Pathol. 2018;188:916–928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29353062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klingenberg M, Matsuda A, Diederichs S, et al. . 
Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017;67:603–618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28438689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roderburg C, Luedde M, Cardenas DV, et al. . 
miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol. 2013;58:736–742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23183523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roderburg C, Urban GW, Bettermann K, et al. . 
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20890893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang GL, Li YX, Zheng SQ, et al. . 
Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res. 2010;88:169–175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20728471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu J, Xu YX, Li CF, et al. . 
A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liver. Sci Rep. 2015;5:10572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4505342</ArticleId>
            <ArticleId IdType="pubmed">26184825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin Y, Deng W, Pang J, et al. . 
The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3 K/Akt/mTOR/ULK1 signaling-induced autophagy. Cell Microbiol. 2017;19:e12709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27886437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng W, Zhang X, Ma Z, et al. . 
MicroRNA-125b-5p mediates post-transcriptional regulation of hepatitis B virus replication via the LIN28B/let-7 axis. RNA Biol. 2017;14:1389–1398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5711457</ArticleId>
            <ArticleId IdType="pubmed">28267418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Zhang E, Ma Z, et al. . 
Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1. Hepatology. 2011;53:1476–1485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21520166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Werner M, Driftmann S, Kleinehr K, et al. . 
All-in-one: advanced preparation of human parenchymal and non-parenchymal liver cells. PLoS One. 2015;10:e0138655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4583235</ArticleId>
            <ArticleId IdType="pubmed">26407160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Zhou P, Deng W, et al. . 
Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation. Clin Microbiol Infect. 2016;22:384 e381–384 e310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26802212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei S, Wang L, Zhang L, et al. . 
ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3 K/AKT signaling pathway. Tumour Biol. 2016;37:12813–12821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27449034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teng CF, Wu HC, Tsai HW, et al. . 
Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. Hepatology. 2011;54:1199–1207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21735472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Rie D, Abugessaisa I, Alam T, et al. . 
An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol. 2017;35:872–878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5767576</ArticleId>
            <ArticleId IdType="pubmed">28829439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G, Dong F, Xu Z, et al. . 
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. BMC Cancer. 2017;17:805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5709924</ArticleId>
            <ArticleId IdType="pubmed">29191172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z, Diaz G, Pollicino T, et al. . 
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure. Proc Natl Acad Sci USA. 2018;115:E11369–E11378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6275524</ArticleId>
            <ArticleId IdType="pubmed">30420516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winther TN, Bang-Berthelsen CH, Heiberg IL, et al. . 
Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B. PLoS One. 2013;8:e58236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3587589</ArticleId>
            <ArticleId IdType="pubmed">23469271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Ree MH, Jansen L, Kruize Z, et al. . 
Plasma microRNA levels are associated with hepatitis B e antigen status and treatment response in chronic hepatitis B patients. J Infect Dis. 2017;215:1421–1429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28368488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Wen Y, Liu Z, et al. . 
VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer. Mol Ther Nucleic Acids. 2021;23:324–335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7779536</ArticleId>
            <ArticleId IdType="pubmed">33425490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Miu KK, Zhang X, et al. . 
Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor. JHEP Rep. 2020;2:100179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7588854</ArticleId>
            <ArticleId IdType="pubmed">33134908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Chen J, Liu Y, et al. . 
Hepatitis B virus induces autophagy to promote its replication by the axis of miR-192-3p-XIAP through NF kappa B signaling. Hepatology. 2019;69:974–992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6519203</ArticleId>
            <ArticleId IdType="pubmed">30180281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winther TN, Heiberg IL, Bang-Berthelsen CH, et al. . 
Hepatitis B surface antigen quantity positively correlates with plasma levels of microRNAs differentially expressed in immunological phases of chronic hepatitis B in children. PLoS One. 2013;8:e80384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3823657</ArticleId>
            <ArticleId IdType="pubmed">24244683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunetto MR, Cavallone D, Oliveri F, et al. . 
A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection. PLoS One. 2014;9:e110782.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4211710</ArticleId>
            <ArticleId IdType="pubmed">25350115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li D, Liu Y, Li H, et al. . 
MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5). FEBS Lett. 2015;589:68–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25433291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo H, Zhou T, Jiang D, et al. . 
Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol. 2007;81:10072–10080.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2045390</ArticleId>
            <ArticleId IdType="pubmed">17609269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hay N, Sonenberg N.. 
Upstream and downstream of mTOR. Genes Dev. 2004;18:1926–1945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15314020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim YC, Guan KL.. 
mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125:25–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4382265</ArticleId>
            <ArticleId IdType="pubmed">25654547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huning L, Kunkel GR.. 
The ubiquitous transcriptional protein ZNF143 activates a diversity of genes while assisting to organize chromatin structure. Gene. 2021;769:145205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33031894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuster C, Krol A, Carbon P.. 
Two distinct domains in Staf to selectively activate small nuclear RNA-type and mRNA promoters. Mol Cell Biol. 1998;18:2650–2658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC110644</ArticleId>
            <ArticleId IdType="pubmed">9566884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye B, Yang G, Li Y, et al. . 
ZNF143 in chromatin looping and gene regulation. Front Genet. 2020;11:338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7154149</ArticleId>
            <ArticleId IdType="pubmed">32318100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paek AR, You HJ.. 
GAIP-interacting protein, C-terminus is involved in the induction of zinc-finger protein 143 in response to insulin-like growth factor-1 in colon cancer cells. Mol Cells. 2011;32:415–419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3887697</ArticleId>
            <ArticleId IdType="pubmed">21909943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L, Huo Q, Ge C, et al. . 
ZNF143-mediated h3k9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma. Cancer Res. 2020;80:2599–2611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32312832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kai K, Dittmar RL, Sen S.. 
Secretory microRNAs as biomarkers of cancer. Semin Cell Dev Biol. 2018;78:22–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29258963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang XN, Chen CC, Wu M, et al. . 
Plasma microRNA profile as a predictor of early virological response to interferon treatment in chronic hepatitis B patients. Antivir Ther. 2012;17:1243–1253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22997154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akamatsu S, Hayes CN, Tsuge M, et al. . 
Differences in serum microRNA profiles in hepatitis B and C virus infection. J Infect. 2015;70:273–287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25452043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enomoto Y, Takagi R, Naito Y, et al. . 
Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs. Sci Rep. 2017;7:7780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5552845</ArticleId>
            <ArticleId IdType="pubmed">28798470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novellino L, Rossi RL, Bonino F, et al. . 
Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs. PLoS One. 2012;7:e31952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3314627</ArticleId>
            <ArticleId IdType="pubmed">22470417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen R, Wu JC, Liu T, et al. . 
MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients. J Dig Dis. 2017;18:115–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28127890</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
